18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Sporadic and familial CJD: classification and characterisation.

      British Medical Bulletin
      Adolescent, Adult, Age of Onset, Aged, Aged, 80 and over, Amyloid, chemistry, genetics, Ataxia, etiology, Brain, pathology, Brain Chemistry, Cognition Disorders, Creutzfeldt-Jakob Syndrome, classification, diagnosis, Dementia, Genetic Diseases, Inborn, Genotype, Haplotypes, Humans, Immunohistochemistry, Insomnia, Fatal Familial, Middle Aged, Mutation, PrPC Proteins, PrPSc Proteins, Prions, Protein Precursors

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Prion diseases are unique transmissible neurodegenerative diseases that have diverse phenotypes and can be familial, sporadic, or acquired by infection. Recent findings indicate that the PrP genotype and the PrP(Sc) type have a major influence on the disease phenotype in both sporadic and familial human prion diseases. This review attempts to classify and characterise sporadic and familial Creutzfeldt-Jakob disease (CJD) as a function of these two disease determinants. Based on the genotype at codon 129 on both PRNP alleles, the size of protease resistant PrP(Sc) fragments and disease phenotype, we divide sporadic CJD into six subtypes: sCJDMM1/sCJDMV1, sCJDVV2, sCJDMV2, sCJDMM2, sCJDVV1, and sporadic fatal insomnia (sFI). Familial CJD is classified into many haplotypes based on the PRNP mutation and codon 129 (and other polymorphic codons) on the mutant allele. The clinical and pathological features are summarised for each sporadic CJD subtype and familial CJD haplotype.

          Related collections

          Author and article information

          Comments

          Comment on this article